These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6108378)

  • 61. [Drug therapy of heart failure, rhythm disorders and collapse in the acute phase of myocardial infarct].
    Bensaid J; Penther P; Coblence B
    Ann Cardiol Angeiol (Paris); 1968; 17(4):347-52. PubMed ID: 5745234
    [No Abstract]   [Full Text] [Related]  

  • 62. [Interrelationship between electrophysiological markers of arrhythmogenicity and psychoemotional status of patients with myocardial infarction].
    Lebedeva NB; Lebedev OV; Berns SA; Barbarash LS; Barbarash NA; Barbarash OL
    Kardiologiia; 2003; 43(2):70-1. PubMed ID: 12913989
    [No Abstract]   [Full Text] [Related]  

  • 63. [Treatment of heart arrhythmias in the acute phase of myocardial infarct with practolol].
    Kojoukharov DD
    G Ital Cardiol; 1972; 2(2):283-6. PubMed ID: 4401612
    [No Abstract]   [Full Text] [Related]  

  • 64. Glucagon and haemodynamics of acute myocardial infarction.
    Eddy JD; O'Brien ET; Singh SP
    Br Med J; 1969 Dec; 4(5684):663-5. PubMed ID: 5359922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Gettes LS
    Cardiovasc Clin; 1970; 2(2):211-37. PubMed ID: 4149974
    [No Abstract]   [Full Text] [Related]  

  • 66. [Drug prevention of cardiac rhythm disorders during the acute period of myocardial infarct].
    Leshchinskiĭ LA; Lazarenko VG; Shinkareva IA
    Kardiologiia; 1976 Jan; 16(1):48-53. PubMed ID: 1271621
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Prevention of arrhythmia in myocardial infarct (secondary prevention)].
    Gertsch M
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1181-7. PubMed ID: 2877483
    [No Abstract]   [Full Text] [Related]  

  • 68. [Disorders of cardiac rhythm and conduction in acute myocardial infarct during the first 3 days and the effectiveness of their treatment].
    Kochlamazashvili AI
    Ter Arkh; 1975; 47(7):44-51. PubMed ID: 1224349
    [No Abstract]   [Full Text] [Related]  

  • 69. [Pindolol in foreign medical practice].
    Ducloux M
    Bull Soc Med Afr Noire Lang Fr; 1973; 18(1):55-9. PubMed ID: 4149294
    [No Abstract]   [Full Text] [Related]  

  • 70. [Treatment of cardiac rhythm disorders with beta-adrenergic blockaders, propranolol, benzodixin, visken, eraldin and trazikor].
    Doshchitsin VL; Simonov VI
    Kardiologiia; 1971; 11(12):49-54. PubMed ID: 4112455
    [No Abstract]   [Full Text] [Related]  

  • 71. [Hemodynamic effects of intravenous injection of beta-adrenergic inhibitor (Pindolol) in man].
    Scebat L; Rocha P; Ourbak P; Renais J; Lenègre J
    G Ital Cardiol; 1972; 2(5):626-35. PubMed ID: 4404052
    [No Abstract]   [Full Text] [Related]  

  • 72. [Therapy of postoperative arrhythmias (author's transl)].
    Vormittag E
    Wien Klin Wochenschr; 1979 Apr; 91(8):267-71. PubMed ID: 88135
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias.
    Singh BN
    N Z Med J; 1973 Dec; 78(504):482-6. PubMed ID: 4130662
    [No Abstract]   [Full Text] [Related]  

  • 74. [Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct].
    De Ambroggi L; Perotta GM; Satolli R; Lotto A
    Boll Soc Ital Cardiol; 1977; 22(8):1343-51. PubMed ID: 36116
    [No Abstract]   [Full Text] [Related]  

  • 75. [Use of beta-adrenergic blocking agents in the therapy of cardiac arrhythmias].
    Streian C; Hodas C; Gavrilescu S
    Med Interna (Bucur); 1974 May; 26(5):583-92. PubMed ID: 4152240
    [No Abstract]   [Full Text] [Related]  

  • 76. [Effect of blockaders of cardiac beta-adrenergic structures on the central hemodynamics and contractile function of the myocardium in acute experimental coronary insufficiency].
    Ol'binskaia LI; Sandrikov VA; Ptashnikova TN; Sadovnikov VI; Trekova NA
    Kardiologiia; 1979 Sep; 19(9):100-3. PubMed ID: 40059
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Change in the central and regional (brain) hemodynamics in the treatment of hypertension using beta-adrenergic blockaders].
    Erina EV; Basishvili NZ; Elizarova NA; Kheĭmets GI
    Kardiologiia; 1976 Jul; 16(7):82-7. PubMed ID: 10464
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
    Lil'in ET; Vavilova TA; Mar'in MI
    Klin Med (Mosk); 1983 Sep; 61(9):85-9. PubMed ID: 6139506
    [No Abstract]   [Full Text] [Related]  

  • 79. [Differential use of glucagon in acute period of myocardial infarct].
    Golikof AP; Berestov AA; Maĭorov NI
    Kardiologiia; 1979 Jan; 19(1):11-7. PubMed ID: 312354
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm.
    Frishman W; Davis R; Strom J; Elkayam U; Stampfer M; Ribner H; Weinstein J; Sonnenblick E
    Am Heart J; 1979 Sep; 98(3):393-98. PubMed ID: 38659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.